RayKnowChina Research Map
Shortlist

Cancer

Pancreatic cancer in Chengdu

成都 胰腺癌

All diseases in Chengdu

4 hospitals in Chengdu

Order: papers led on pancreatic cancer, 2021–2025, then A–Z. Research activity, not a rating of care.

Only hospitals listed for pancreatic cancer: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Chengdu may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.

  1. 163 papers led
  2. 16 papers led
    No open trial led
  3. 5 papers led
    No open trial led
  4. 2 papers led
    No open trial led

Pancreatic cancer in every city Chengdu on the disease page, with the national map

21

open trials on pancreatic cancer with a hospital in Chengdu

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Chengdu as lead sponsor or study site. 9 of them are led by a hospital in Chengdu. Check the registry for the current status. Whether someone can take part is decided by the study team.

Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.

  1. Recruiting
    NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer
    Phase
    Phase 1/Phase 2
    Started
    2026-04
    Posted
    Registry
    NCT07595172

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  2. Recruiting
    A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
    Phase
    Phase 1/Phase 2
    Started
    2026-09
    Posted
    Registry
    NCT07678593

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenyang, Wuhan, Xi'an, Zhengzhou

  3. Recruiting
    YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
    Phase
    Phase 1
    Started
    2026-08
    Posted
    Registry
    NCT07763301

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  4. Recruiting
    GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Metastatic PDAC
    Phase
    Phase 1/Phase 2
    Started
    2026-09
    Posted
    Registry
    NCT07802184

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  5. Recruiting
    A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT07101679

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  6. Recruiting
    A Study of GV20-0251 in Advanced or Refractory Solid Tumors
    Phase
    Phase 1
    Started
    2025-09
    Posted
    Registry
    NCT07106827

    Age 18 years to Not stated (registered criteria)

    Led by West China HospitalChengdu

  7. Recruiting
    A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-12
    Posted
    Registry
    NCT07255404

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Kunming, Nanchang, Shanghai, Shenyang, Wuhan, Zhengzhou

  8. Recruiting
    Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
    Phase
    Phase 3
    Started
    2025-07
    Posted
    Registry
    NCT07823049

    Age not stated (registered criteria)

    Lead sponsor is not a listed hospital; 36 listed hospitals as study sitesBeijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanchang, Nanjing, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi'an, Yangzhou, Yinchuan, Zhengzhou

  9. Recruiting
    A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
    Phase
    Phase 2
    Started
    2024-02
    Posted
    Registry
    NCT06172478

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesChengdu, Guangzhou

  10. Recruiting
    Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
    Phase
    Phase 1
    Started
    2024-04
    Posted
    Registry
    NCT06344156

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  11. Recruiting
    A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
    Phase
    Phase 2/Phase 3
    Started
    2024-05
    Posted
    Registry
    NCT06361888

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 41 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Linyi, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shenzhen, Suzhou, Tianjin, Wenzhou, Wuhan, Xi'an, Xiamen, Zhengzhou

  12. Recruiting
    A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
    Phase
    Phase 1/Phase 2
    Started
    2024-06
    Posted
    Registry
    NCT06428409

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 6 listed hospitals as study sitesBeijing, Changsha, Chengdu, Fuzhou, Shanghai, Wuhan

  13. Recruiting
    Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
    Phase
    Phase 1/Phase 2
    Started
    2024-11
    Posted
    Registry
    NCT07433283

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Haikou, Harbin, Shanghai, Zhengzhou

  14. Recruiting
    Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
    Phase
    Not given
    Started
    2023-02
    Posted
    Registry
    NCT05847855

    Age 18 years to Not stated (registered criteria)

    Led by Fudan University Shanghai Cancer Center; 1 listed hospital as study siteChengdu, Shanghai

  15. Recruiting
    A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
    Phase
    Phase 2
    Started
    2023-10
    Posted
    Registry
    NCT06008288

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 29 listed hospitals as study sitesBeijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Tianjin, Wuhan, Xi'an, Zhengzhou

  16. Recruiting
    A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2023-10
    Posted
    Registry
    NCT06111274

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesChengdu, Harbin, Shanghai, Wuhan

  17. Recruiting
    Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
    Phase
    Phase 1/Phase 2
    Started
    2023-12
    Posted
    Registry
    NCT06799637

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Hefei, Kunming, Luoyang, Shanghai, Wuhan

  18. Not yet recruiting
    JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure
    Phase
    Phase 1/Phase 2
    Started
    2026-09
    Posted
    Registry
    NCT07175389

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  19. Not yet recruiting
    Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer
    Phase
    Phase 1
    Started
    2026-06
    Posted
    Registry
    NCT07637786

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  20. Not yet recruiting
    A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic Cancer
    Phase
    N/A
    Started
    2026-10
    Posted
    Registry
    NCT07928362

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin Hospital; 4 listed hospitals as study sitesChengdu, Qingdao, Shanghai, Xi'an

  21. Not yet recruiting
    Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC
    Phase
    Phase 1
    Started
    2024-05
    Posted
    Registry
    NCT06346808

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Disease research in Chengdu

Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.

A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.

Papers led and open trials led by hospitals in Chengdu, by disease
CancerBlood disordersOther diseases
HospitalNasopharyngeal carcinomaOesophageal squamous cell carcinomaHepatocellular carcinomaStomach cancerLung cancerPancreatic cancerBreast cancerGliomaHepatoblastomaRetinoblastomaChordomaOsteosarcomaGastrointestinal stromal tumourNeuroblastomaEwing sarcomaMultiple myelomaB-cell acute lymphoblastic leukaemiaAplastic anaemiaHaemophagocytic lymphohistiocytosisLymphomaBeta thalassaemiaHaemophilia AAtypical haemolytic uraemic syndromeThrombotic thrombocytopenic purpuraFanconi anaemiaNeuromyelitis optica spectrum disorderIgG4-related diseaseMyasthenia gravisMoyamoya diseaseWilson diseaseBiliary atresiaCoronary heart diseaseCongenital heart diseaseScoliosisAnti-NMDA receptor encephalitisTakayasu arteritisHepatic echinococcosisIdiopathic pulmonary fibrosisLymphangioleiomyomatosisAmyotrophic lateral sclerosisSpinal muscular atrophyFabry diseasePompe diseaseDuchenne muscular dystrophyBehçet diseaseAlport syndromeIgA nephropathyGaucher diseaseNiemann–Pick disease type COsteogenesis imperfectaPrimary biliary cholangitisPrimary sclerosing cholangitisCongenital diaphragmatic herniaHirschsprung diseaseInherited epidermolysis bullosaHereditary angioedemaFamilial adenomatous polyposisLeber hereditary optic neuropathyMajeed syndromeNGLY1 deficiencyISG15 deficiencyShortlist
Affiliated Hospital of Chengdu University成都大学附属医院7none301441none20nonenonenone15nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone8nonenonenonenonenone8none3nonenonenonenone2nonenonenonenonenone2nonenonenonenonenonenonenonenonenonenone
Affiliated Hospital of Southwest Jiaotong University成都市第三人民医院nonenonenonenonenonenonenonenonenonenone105nonenonenonenonenonenonenone12nonenonenonenonenonenonenonenonenone7none4nonenone01nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Affiliated Sport Hospital of Chengdu Sport University成都体育学院附属体育医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Affiliated Women's and Children's Hospital of Chengdu Medical College四川省妇幼保健院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone4none0nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Eighth People's Hospital成都市第八人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Fifth People's Hospital成都市第五人民医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu First People's Hospital成都市中西医结合医院nonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Jinniu District People's Hospital成都市金牛区人民医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Qingbaijiang District People's Hospital成都市青白江区人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Second People's Hospital成都市第二人民医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Seventh People's Hospital成都市第七人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Child Health Hospitalnonenonenonenone01 opennonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Children's Central Hospital, University of Electronic Science成都市妇女儿童中心医院nonenonenonenonenonenonenonenone2nonenonenonenone1nonenonenonenonenonenone01nonenonenonenonenonenonenonenonenonenone10none2nonenone1none1nonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
First Affiliated Hospital of Chengdu Medical College成都医学院第一附属医院nonenone86none2nonenonenone2none1nonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenone14nonenonenonenonenonenone1none1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Fourth Hospital of Sichuan University四川大学华西第四医院nonenonenonenonenonenone21nonenonenonenone0none1nonenonenonenone2nonenonenonenonenonenonenonenonenonenone5nonenonenonenonenonenonenone1none2nonenonenone1nonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Gastrointestinal Cancer Centre华西-牛津消化道肿瘤研究中心nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenone
People's Liberation Army The General Hospital中国人民解放军西部战区总医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sciences Sichuan Translational Medicine Research Hospital中国科学院四川转化医学研究医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Second Affiliated Hospital of Chengdu Medical College成都医学院第二附属医院(核工业四一六医院)nonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone3nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sichuan Cancer Hospital四川省肿瘤医院252 open501 open191 open131117 open5561 opennonenonenonenone031nonenonenonenonenone17nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sichuan Provincial People's Hospital四川省人民医院35422453163125nonenone1632none13nonenonenone9none01nonenone7none2nonenonenone155none201017none5nonenonenonenone11101 opennonenonenone011nonenone11nonenonenonenone
Sichuan Taikang Hospital四川泰康医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
West China Hospital四川大学华西医院442 open716 open39216 open1684 open68224 open1639 open31310 open1691 open413363352 open95914121451 open24none2136111611none7872 open127371 open2231431260152262340none011351420nonenonenonenone
West China Hospital of Stomatology四川大学华西口腔医院1nonenonenonenonenonenonenonenonenonenone5none1nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
West China Second University Hospital四川大学华西第二医院nonenonenonenonenonenonenone91nonenone1131none237421nonenonenonenonenone0nonenone41552251none21120021011nonenone2nonenone31nonenonenonenonenonenonenone
Xindu District People's Hospital成都市新都区人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone

Column labels are short names. Choose one to open that disease in Chengdu.

Other cities nearby

Straight-line distance from the city centre; counts are hospitals listed for pancreatic cancer.

Counts are listed hospitals only, not every hospital in each city.

Where these numbers come from

Papers

English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions

Trials

ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Chengdu on ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data